Clinical trial
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
NCT02981069
Study timeline
Study start (actual)2017-12-15Date precision: day
Registry last updated2023-07-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
ExenatideDRUG · verified · RxNorm: exenatide
PlaceboDRUG
Sponsors & collaborators
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02981069 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.